Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Short-chain fatty acids in nonalcoholic fatty liver disease: New prospects for short-chain fatty acids as therapeutic targets
Xinyu Li, Maozhang He, Xinrui Yi, et al.
Heliyon (2024) Vol. 10, Iss. 5, pp. e26991-e26991
Open Access | Times Cited: 15

Showing 15 citing articles:

Current Therapeutic Landscape for Metabolic Dysfunction-Associated Steatohepatitis
Arun George Devasia, Adaikalavan Ramasamy, Chen Huei Leo
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 4, pp. 1778-1778
Open Access | Times Cited: 1
Exploring Extracellular Vesicles: A Novel Approach in Nonalcoholic Fatty Liver Disease
Ana Isabel Vigil Medina, Mengdie Shi, Yanyan Wang, et al.
Journal of Agricultural and Food Chemistry (2025)
Closed Access
Sodium alginate alleviated isoniazid-induced liver injury by modulating fecal metabolites and gut microbiota
Xinfang Wang, Jingkai Zhang, Xia Xin, et al.
International Journal of Biological Macromolecules (2025), pp. 141149-141149
Closed Access
Alleviating effect of Lactobacillus fermentum E15 on hyperlipidemia and hepatic lipid metabolism in zebrafish fed by a high-fat diet through the production of short-chain fatty acids
Yishu Chen, Kangdi Zheng, Yang Leng, et al.
Frontiers in Nutrition (2025) Vol. 12
Open Access
The Role of Short-Chain Fatty Acids in Metabolic Dysfunction-Associated Steatotic Liver Disease and Other Metabolic Diseases
Eliane Münte, Phillipp Hartmann
Biomolecules (2025) Vol. 15, Iss. 4, pp. 469-469
Open Access
Role of short-chain fatty acids in non-alcoholic fatty liver disease and potential therapeutic targets
Xiang Qin, Mengyao Chen, Beihui He, et al.
Frontiers in Microbiology (2025) Vol. 16
Open Access
Inflammation in MASLD Progression and Cancer
Yeon Soo Kim, Y. C. Park, Hyunsoo Rho, et al.
JHEP Reports (2025), pp. 101414-101414
Open Access
Hypogonadism and nonalcoholic fatty liver disease
Kasiani Papadimitriou, Athanasios Mousiolis, Gesthimani Mintziori, et al.
Endocrine (2024) Vol. 86, Iss. 1, pp. 28-47
Closed Access | Times Cited: 3
Mediterranean diet for the management of metabolic dysfunction‐associated steatotic liver disease in non‐Mediterranean, Western countries: What's known and what's needed?
Ayesha Sualeheen, Sze‐Yen Tan, Ekavi N. Georgousopoulou, et al.
Nutrition Bulletin (2024)
Open Access | Times Cited: 2
Quercetin: A Promising Candidate for the Management of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
Julia Markowska, Kamila Kasprzak‐Drozd, Przemysław Niziński, et al.
Molecules (2024) Vol. 29, Iss. 22, pp. 5245-5245
Open Access | Times Cited: 2
Short-chain fatty acids in clinical practice: where are we?
Robert G. Martindale, Manpreet S. Mundi, Ryan T. Hurt, et al.
Current Opinion in Clinical Nutrition & Metabolic Care (2024) Vol. 28, Iss. 2, pp. 54-60
Closed Access | Times Cited: 1
Metformin's modulation of gut microbiota and its implications for non-alcoholic fatty liver disease: A network pharmacology and molecular dynamics study
Sarvesh Sabarathinam, Ramesh Venkatachalapathy, Akash Jayaraman
Human Gene (2024), pp. 201364-201364
Closed Access
Potential application of the simulator of the human intestinal microbial ecosystem in metabolic dysfunction-associated steatotic liver disease
Gabriele Castelnuovo, Nuria Pérez-Díaz-del-Campo, Séverine Dubois, et al.
Minerva Biotechnology and Biomolecular Research (2024) Vol. 36, Iss. 4
Closed Access
Interplay of Oxidative Stress, Gut Microbiota, and Nicotine in Metabolic-Associated Steatotic Liver Disease (MASLD)
Irene Mignini, Linda Galasso, Giulia Piccirilli, et al.
Antioxidants (2024) Vol. 13, Iss. 12, pp. 1532-1532
Open Access
Etiology-Dependent Microbiome Differences in Hepatocellular Carcinoma Development
Nevena Todorović, Serena Martinelli, Giulia Nannini, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 24, pp. 13510-13510
Open Access
Page 1

Scroll to top